Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions
Clinical trial NCT01712126 · COMPLETED
Trial details
- NCT number
- NCT01712126
- Sponsor
- Roxane Laboratories
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2007-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.